Showing 221 - 240 results of 41,460 for search '(( 50 ((ng decrease) OR (((teer decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 0.83s Refine Results
  1. 221

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  2. 222

    The 5’SS motif decreases mRNA stability and promotes nuclear retention. by Eliza S. Lee (715538)

    Published 2015
    “…Note that the relative level of <i>c-ftz-Δi-V5-His</i> decreases over the first 60 min until 40–50% of the mRNA remains, after which point the ratio is stable. …”
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229
  10. 230
  11. 231

    The NG50 of ccTSA on datasets from 4 organisms with different sequence coverage and k-mer values. by Jung Ho Ahn (157844)

    Published 2012
    “…The k-mer values were varied from 19 to 35 on 36 bp data and from 37 to 73 on 76 bp data. In most datasets, NG50 values increased then decreased as we increased the k-mer values. …”
  12. 232
  13. 233

    PIN1 silencing leads to decreases in the protein levels of HIF-1α. by Hyeong-jun Han (846566)

    Published 2016
    “…<p>A) Silencing of PIN1 expression via RNAi reduces the protein levels of HIF-1α in HCT116 cells. …”
  14. 234
  15. 235
  16. 236
  17. 237

    IFNγ increases PRL immunoreactivity in the hair follicle, whilst TNFα decreases follicular PRL immunoreactivity. by Ewan A. Langan (405804)

    Published 2013
    “…Results were pooled from 3 ♀ subjects (Aged 44–68), 14–16 HFs per group in total. In contrast, TNFα 5 ng/ml significantly decreased PRL IR (E). PRL IR is shown in (F) control hair follicles and those treated with (G) TNFα 0.5 ng/ml and (H) TNFα 5 ng/ml. …”
  18. 238
  19. 239
  20. 240